Sandra Torregrosa‐Allen

867 total citations · 1 hit paper
26 papers, 657 citations indexed

About

Sandra Torregrosa‐Allen is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Sandra Torregrosa‐Allen has authored 26 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Biomedical Engineering and 7 papers in Molecular Biology. Recurrent topics in Sandra Torregrosa‐Allen's work include Nanoplatforms for cancer theranostics (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Sandra Torregrosa‐Allen is often cited by papers focused on Nanoplatforms for cancer theranostics (6 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (4 papers). Sandra Torregrosa‐Allen collaborates with scholars based in United States, Canada and South Korea. Sandra Torregrosa‐Allen's co-authors include Bennett D. Elzey, Bo Sun, Yoon Yeo, You‐Yeon Won, Yun Chang, Xiaoping Bao, Xiaojun Lian, Gyuhyung Jin, Qing Deng and Ramizah Syahirah and has published in prestigious journals such as Nature Communications, Biomaterials and Cancer Research.

In The Last Decade

Sandra Torregrosa‐Allen

24 papers receiving 641 citations

Hit Papers

CAR-neutrophil mediated d... 2023 2026 2024 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Torregrosa‐Allen United States 14 217 205 190 181 140 26 657
Kewen Lei China 13 261 1.2× 182 0.9× 233 1.2× 153 0.8× 200 1.4× 20 782
Feifei Yang China 16 239 1.1× 282 1.4× 340 1.8× 211 1.2× 215 1.5× 32 837
Hyunjoon Kim United States 14 214 1.0× 210 1.0× 272 1.4× 133 0.7× 141 1.0× 22 616
James W. Opzoomer United Kingdom 8 171 0.8× 329 1.6× 275 1.4× 370 2.0× 112 0.8× 11 828
Allison N. Schorzman United States 14 213 1.0× 236 1.2× 116 0.6× 181 1.0× 250 1.8× 24 772
Wan Su Yun South Korea 16 411 1.9× 241 1.2× 144 0.8× 131 0.7× 225 1.6× 25 726
Yael Ben‐Nun Israel 13 144 0.7× 248 1.2× 135 0.7× 196 1.1× 65 0.5× 17 658
Amanda M. Hamilton Canada 16 220 1.0× 242 1.2× 104 0.5× 124 0.7× 116 0.8× 37 749
Myrofora Panagi Cyprus 15 297 1.4× 297 1.4× 223 1.2× 312 1.7× 109 0.8× 24 883
Margit M. Janát‐Amsbury United States 16 138 0.6× 365 1.8× 109 0.6× 184 1.0× 202 1.4× 34 856

Countries citing papers authored by Sandra Torregrosa‐Allen

Since Specialization
Citations

This map shows the geographic impact of Sandra Torregrosa‐Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Torregrosa‐Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Torregrosa‐Allen more than expected).

Fields of papers citing papers by Sandra Torregrosa‐Allen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Torregrosa‐Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Torregrosa‐Allen. The network helps show where Sandra Torregrosa‐Allen may publish in the future.

Co-authorship network of co-authors of Sandra Torregrosa‐Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Torregrosa‐Allen. A scholar is included among the top collaborators of Sandra Torregrosa‐Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Torregrosa‐Allen. Sandra Torregrosa‐Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Subhadeep, et al.. (2025). Supinoxin blocks small cell lung cancer progression by inhibiting mitochondrial respiration through DDX5. iScience. 28(4). 112219–112219. 4 indexed citations
2.
Torregrosa‐Allen, Sandra, Xiaoling Jin, Sang-Yoon Kim, et al.. (2025). Intrapulmonary Spreading of Pharyngeally Instilled Liquids: Impact of Nanoparticle Concentration and PEG Lubrication in Polymer Lung Surfactant Solutions. Molecular Pharmaceutics. 22(10). 5975–5988.
3.
Lubecka, Katarzyna, Sandra Torregrosa‐Allen, Bennett D. Elzey, et al.. (2025). AMPK‐Dependent Epigenetic Regulation of Metabolism Mediates the Anti‐Cancer Action of Pterostilbene in Hepatocellular Carcinoma. Molecular Nutrition & Food Research. 69(23). e70217–e70217.
4.
Yang, T.Y., Katarzyna Lubecka, Sushil Kumar, et al.. (2024). Pterostilbene Targets Hallmarks of Aging in the Gene Expression Landscape in Blood of Healthy Rats. Molecular Nutrition & Food Research. 68(24). e2400662–e2400662. 2 indexed citations
5.
Lupo, Kyle B., Xue Yao, Jiao Wang, et al.. (2024). synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature Communications. 15(1). 1909–1909. 25 indexed citations
6.
Shin, Sung‐Ho, et al.. (2023). Radiation-induced photodynamic therapy using calcium tungstate nanoparticles and 5-aminolevulinic acid prodrug. Biomaterials Science. 11(18). 6311–6324. 3 indexed citations
7.
Chang, Yun, Xuechao Cai, Ramizah Syahirah, et al.. (2023). CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nature Communications. 14(1). 2266–2266. 127 indexed citations breakdown →
8.
Chang, Yun, Gyuhyung Jin, Qian Luo, et al.. (2023). Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioactive Materials. 27. 168–180. 21 indexed citations
9.
Lupo, Kyle B., Sandra Torregrosa‐Allen, Bennett D. Elzey, et al.. (2023). TIGIT contributes to the regulation of 4-1BB and does not define NK cell dysfunction in glioblastoma. iScience. 26(12). 108353–108353. 3 indexed citations
10.
Chang, Yun, Ramizah Syahirah, Stephanie N. Oprescu, et al.. (2022). Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. Biomaterials. 285. 121569–121569. 14 indexed citations
11.
Chambers, Andrea M., Kyle B. Lupo, Jiao Wang, et al.. (2022). Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. eLife. 11. 23 indexed citations
12.
Chang, Yun, Ramizah Syahirah, Xuepeng Wang, et al.. (2022). Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy. Cell Reports. 40(3). 111128–111128. 77 indexed citations
13.
Dayal, Neetu, Eva Řezníčková, Sandra Torregrosa‐Allen, et al.. (2021). 3H-Pyrazolo[4,3-f]quinoline-Based Kinase Inhibitors Inhibit the Proliferation of Acute Myeloid Leukemia Cells In Vivo. Journal of Medicinal Chemistry. 64(15). 10981–10996. 14 indexed citations
14.
Alpsoy, Aktan, Sagar M. Utturkar, Benjamin C. Carter, et al.. (2020). BRD9 Is a Critical Regulator of Androgen Receptor Signaling and Prostate Cancer Progression. Cancer Research. 81(4). 820–833. 57 indexed citations
15.
Opoku‐Temeng, Clement, Eun Yong Choi, Elizabeth Chang, et al.. (2019). Amino alkynylisoquinoline and alkynylnaphthyridine compounds potently inhibit acute myeloid leukemia proliferation in mice. EBioMedicine. 40. 231–239. 11 indexed citations
16.
Misra, Rahul, Jae‐Won Lee, Sandra Torregrosa‐Allen, et al.. (2019). Folic Acid-Conjugated Radioluminescent Calcium Tungstate Nanoparticles as Radio-Sensitizers for Cancer Radiotherapy. ACS Biomaterials Science & Engineering. 5(9). 4776–4789. 13 indexed citations
17.
Misra, Rahul, Sandra Torregrosa‐Allen, Gregory A. Durm, et al.. (2019). Radioluminescent nanoparticles for radiation-controlled release of drugs. Journal of Controlled Release. 303. 237–252. 27 indexed citations
19.
Lee, Jaewon, Ki‐Hyun Kim, Hock Gan Heng, et al.. (2016). Nontoxic Formulations of Scintillation Nanocrystals for Use as X-ray Computed Tomography Contrast Agents. Bioconjugate Chemistry. 28(1). 171–182. 17 indexed citations
20.
Mehtala, Jonathan G., Sandra Torregrosa‐Allen, Bennett D. Elzey, et al.. (2014). Synergistic Effects of Cisplatin Chemotherapy and Gold Nanorod-Mediated Hyperthermia on Ovarian Cancer Cells and Tumors. Nanomedicine. 9(13). 1939–1955. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026